← back to search

Yama F Mujadidi

University of Oxford · GB
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, and Vaccine Coverage and Hesitancy.
h-index
28
citations
14,568
works
74
NIH funding
primary concept
Medicine
email

Recent publications

Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study
The Lancet Microbe 2024cited by 12position: middledoi
Direct inference and control of genetic population structure from RNA sequencing data
Communications Biology 2023cited by 12position: middledoi
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Nature Medicine 2021cited by 1,236position: middledoi
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
The Lancet 2021cited by 1,208position: middledoi
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
The Lancet 2021cited by 258position: middledoi
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial
The Lancet 2021cited by 152position: middledoi
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
The Lancet 2020cited by 5,000position: middledoi
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Nature Medicine 2020cited by 641position: middledoi
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Nature Medicine 2020cited by 338position: middledoi
Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia
Wellcome Open Research 2020cited by 10position: middledoi
Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia
Wellcome Open Research 2020cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2020–2020) · 2 papers (2020–2020)James Meiring · University of Sheffield2 papers (2020–2020)Robert S. Heyderman · University of Liverpool2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020)Andrew J. Pollard · Capgemini (United Kingdom)2 papers (2020–2020)Melita A. Gordon · University of Liverpool2 papers (2020–2020)Deus Thindwa · London School of Hygiene & Tropical Medicine2 papers (2020–2020) · 2 papers (2020–2020)